[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
April 6, 1907


Author Affiliations

Assistant Professor of Pharmacology, Cornell University Medical College; Member of the Council on Pharmacy and Chemistry of the American Medical Association. NEW YORK CITY.

JAMA. 1907;XLVIII(14):1177-1179. doi:10.1001/jama.1907.25220400029001i

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


Strophanthus has not rivaled digitalis in the extent of its use, except, perhaps, for a short time after the former was brought into prominence by Fraser. This is somewhat remarkable in view of the fact that numerous investigators have found that the action of strophanthus presents certain advantages over that of digitalis; thus, strophanthus, and to a greater extent its active principle, strophanthin, act much more promptly than digitalis or digitoxin. Fraenkel found that the action of a single effective dose of digitoxin was delayed for many hours beyond that of a corresponding dose of strophanthin, and while he was unable to induce slowing of the cat's heart from a single non-toxic dose of digitoxin, a single non-toxic dose of strophanthin promptly proved effective. Strophanthus produces much less vasoconstriction in the splanchnic area than digitoxin does, and while this is a disadvantage in shock, it is often desirable in producing

First Page Preview View Large
First page PDF preview
First page PDF preview